Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays.
Research output: Contribution to journal › Article
Low molecular weight heparins (LMWH's) are used to prevent and treat thrombosis. Tests for monitoring LMWH's include anti-factor Xa (anti-FXa), activated partial thromboplastin time (aPTT) and thrombin generation. Anti-FXa is the current gold standard despite LMWH's varying affinities for FXa and thrombin.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY
|Publication status||Published - 2015|
No data available
Related research output
Tinzaparin and enoxaparin in vitro dose response effects on different whole blood and plasma based assaysThomas, O. (Joint first/primary/lead supervisor), Schött, U. (Joint first/primary/lead supervisor)
2014 Jan → 2014 Jun
Activity: Examination and supervision › Supervision of masters students